At a Glance
Dosage
Only in 25I-NBOMe
sublingual
| Level | Dose |
|---|---|
| Threshold | 50 µg |
| Light | 200–500 µg |
| Common | 500–700 µg |
| Strong | 700–1000 µg |
insufflated
| Level | Dose |
|---|---|
| Threshold | 50 µg |
| Light | 200–500 µg |
| Common | 500–700 µg |
| Strong | 700–800 µg |
| Heavy | 800 µg |
Duration
Only in 25I-NBOMe
sublingual
Total: 6 hrs – 10 hrsAfterglow
Onset15 min – 2 hrs
Come Up30 min – 2 hrs
Peak2 hrs – 4 hrs
Offset1 hrs – 4 hrs
Effects
Safety
Interaction: 25I-NBOMe + DOI
No direct interaction data available between these substances. This does not mean the combination is safe.
25I-NBOMe — Dangerous Interactions
No dangerous interactions recorded.
DOI — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between 25I-NBOMe and DOI?
25I-NBOMe is classified as a Psychedelic (Substituted phenethylamines) while DOI is classified as a Psychedelic (Substituted amphetamines). They share 53 effects in common, with 25 effects unique to 25I-NBOMe and 13 unique to DOI.
Is it safe to combine 25I-NBOMe and DOI?
There is no direct interaction data available for combining 25I-NBOMe and DOI. This does not mean the combination is safe. Always exercise caution and research thoroughly.
Which is stronger, 25I-NBOMe or DOI?
25I-NBOMe and DOI are typically administered via different routes, making a direct potency comparison difficult. They belong to different pharmacological profiles and should not be compared by dose alone.